Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis
- PMID: 24844874
- PMCID: PMC4028951
- DOI: 10.5935/abc.20140040
Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis
Abstract
Background: Subclinical cardiovascular disease is prevalent in patients with Metabolic Syndrome (MetSyn). Left ventricular (LV) circumferential strain (εCC) and longitudinal strain (εLL), assessed by Speckle Tracking Echocardiography (STE), are indices of systolic function: shortening is indicated by negative strain, and thus, the more negative the strain, the better the LV systolic function. They have been used to demonstrate subclinical ventricular dysfunction in several clinical disorders.
Objective: We hypothesized that MetSyn is associated with impaired myocardial function, as assessed by STE.
Methods: We analyzed Multi-Ethnic Study of Atherosclerosis (MESA) participants who underwent STE and were evaluated for all MetSyn components.
Results: Among the 133 participants included [women: 63%; age: 65 ± 9 years (mean ± SD)], the prevalence of MetSyn was 31% (41/133). Individuals with MetSyn had lower εCC and lower εLL than those without MetSyn (-16.3% ± 3.5% vs. -18.4% ± 3.7%, p < 0.01; and -12.1% ± 2.5% vs. -13.9% ± 2.3%, p < 0.01, respectively). The LV ejection fraction (LVEF) was similar in both groups (p = 0.09). In multivariate analysis, MetSyn was associated with less circumferential myocardial shortening as indicated by less negative εCC (B = 2.1%, 95%CI:0.6 3.5, p < 0.01) even after adjusting for age, ethnicity, LV mass, and LVEF). Likewise, presence of MetSyn (B = 1.3%, 95%CI:0.3 2.2, p < 0.01) and LV mass (B = 0.02%, 95% CI: 0.01-0.03, p = 0.02) were significantly associated with less longitudinal myocardial shortening as indicated by less negative εLL after adjustment for ethnicity, LVEF, and creatinine.
Conclusion: Left ventricular εCC and εLL, markers of subclinical cardiovascular disease, are impaired in asymptomatic individuals with MetSyn and no history of myocardial infarction, heart failure, and/or LVEF < 50%.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline.Arq Bras Cardiol. 2015 Apr;104(4):274-83. doi: 10.5935/abc.20140209. Epub 2015 Jan 27. Arq Bras Cardiol. 2015. PMID: 25993590 Free PMC article. Clinical Trial.
-
Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.J Am Heart Assoc. 2015 Mar 13;4(3):e001264. doi: 10.1161/JAHA.114.001264. J Am Heart Assoc. 2015. PMID: 25770024 Free PMC article.
-
Systolic and diastolic myocardial mechanics in patients with cardiac disease and preserved ejection fraction: impact of left ventricular filling pressure.J Am Soc Echocardiogr. 2010 Dec;23(12):1273-80. doi: 10.1016/j.echo.2010.09.008. J Am Soc Echocardiogr. 2010. PMID: 20970305
-
Echocardiographic assessment of left ventricular systolic function.J Echocardiogr. 2019 Mar;17(1):10-16. doi: 10.1007/s12574-018-0405-5. Epub 2018 Nov 2. J Echocardiogr. 2019. PMID: 30390189 Review.
-
Myocardial strain imaging: how useful is it in clinical decision making?Eur Heart J. 2016 Apr 14;37(15):1196-207. doi: 10.1093/eurheartj/ehv529. Epub 2015 Oct 27. Eur Heart J. 2016. PMID: 26508168 Free PMC article. Review.
Cited by
-
Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline.Arq Bras Cardiol. 2015 Apr;104(4):274-83. doi: 10.5935/abc.20140209. Epub 2015 Jan 27. Arq Bras Cardiol. 2015. PMID: 25993590 Free PMC article. Clinical Trial.
-
Weight loss therapy for clinical management of patients with some atherosclerotic diseases: a randomized clinical trial.Nutr J. 2015 Nov 25;14:120. doi: 10.1186/s12937-015-0108-y. Nutr J. 2015. PMID: 26608649 Free PMC article. Clinical Trial.
-
Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis.J Cardiovasc Magn Reson. 2017 Jul 18;19(1):52. doi: 10.1186/s12968-017-0367-1. J Cardiovasc Magn Reson. 2017. PMID: 28720123 Free PMC article. Review.
-
Cardiac structure and function with and without metabolic syndrome: the Echocardiographic Study of Latinos (Echo-SOL).BMJ Open Diabetes Res Care. 2018 Aug 13;6(1):e000484. doi: 10.1136/bmjdrc-2017-000484. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 30116540 Free PMC article. Review.
-
Diets high in vegetables, fruits, cereals, and tubers as a protective factor for metabolic syndrome in bank employees.Diabetes Metab Syndr Obes. 2018 Nov 21;11:781-790. doi: 10.2147/DMSO.S184716. eCollection 2018. Diabetes Metab Syndr Obes. 2018. PMID: 30538515 Free PMC article.
References
-
- Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92(2):399–404. - PubMed
-
- Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132. - PubMed
-
- Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol. 2005;46(3):457–463. - PubMed
-
- Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care. 2003;26(4):1251–1257. - PubMed
-
- Hassinen M, Komulainen P, Lakka TA, Vaisanen SB, Haapala I, Gylling H, et al. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med. 2006;166(4):444–449. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials